Consumer Spin-Off Finally Achieved, GSK Will Weigh More M&A

Could Have £12bn To Spend On M&A

 
• By Andrew McConaghie
  
GSK HQ
The spin-off is the biggest restructure in 20 years for the company, which will now focus on pharma and vaccines. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip